Dr. Chan Kui Fat - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery (MBChB) · The Hong Kong College of Pathologists · Medical degree 1995
- InsuranceBeing compiled｜See details
About
Dr. Chan Kui Fat is a registered Pathology specialist in Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)1995
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Chan Kui Fat? Claim page and update insurance →
FAQ
Is Dr. Chan Kui Fat any good?
Dr. Chan Kui Fat is a registered Pathology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Chan Kui Fat do?
Dr. Chan Kui Fat practises in Pathology.
Are you Dr. Chan Kui Fat? Claim this page to update and manage.
ClaimResearch and publications
10 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.EBioMedicine · 2022
- Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.Pathology, research and practice · 2018
- PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.Breast cancer research and treatment · 2017
- Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation.Oncotarget · 2016
- Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line.Cancer cell international · 2016
- IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.International journal of cancer · 2016
- Hyaluronan synthase 2 is an adverse prognostic marker in androgen receptor-negative breast cancer.Journal of clinical pathology · 2016
- Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breast.Journal of clinical pathology · 2016
- Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.Cancer cell international · 2014
- Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.Molecular cancer therapeutics · 2014
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer